Ampio Pharmaceuticals, Inc. (AMPE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.56 Million | -21.12 Million | -14.08 Million | -14.72 Million | -15.38 Million | -12.13 Million |
| Net Income | -8.63 Million | -16.33 Million | -17.07 Million | -15.89 Million | -13.63 Million | 33.98 Million |
| Depreciation & Amortization | 250 Thousand | 1.04 Million | 1.09 Million | 1.17 Million | 1.27 Million | 1.28 Million |
| Deferred income taxes | - | - | -3.49 Million | 72 Thousand | -4.86 Million | -45.17 Million |
| Stock-based compensation | 159 Thousand | 953 Thousand | 2.72 Million | 1.27 Million | 405 Thousand | 443.78 Thousand |
| Change in working capital | 15 Thousand | -2.97 Million | 2.58 Million | -1.98 Million | 1.35 Million | -2.73 Million |
| Other non-cash items | 1.22 Million | -3.81 Million | 80 Thousand | 624 Thousand | 80 Thousand | 60 Thousand |
| Investing Cash Flow | - | - | -97 Thousand | -63 Thousand | -22 Thousand | -564.27 Thousand |
| Investments in PPE | - | - | -97 Thousand | -63 Thousand | -22 Thousand | -564.27 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 98 Thousand | -111.00 | 30.73 Million | 25.6 Million | 14.35 Thousand | 12.07 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -79.00 | -186 Thousand | - | - | - |
| Common Stock Issuance | 98 Thousand | -32 Thousand | 33.01 Million | 26.19 Million | 14.35 Million | 12.07 Million |
| Other Financing Activities | -98 Thousand | -32.00 | -2.09 Million | -585 Thousand | 14.35 Thousand | 12.07 Thousand |
| Accounts receivables | -920 Thousand | - | - | - | - | - |
| Accounts payables | 1.25 Million | -3.95 Million | 3262 Billion | -2475 Billion | 2.7 Million | -1.46 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 935 Thousand | 985 Thousand | -3261.99 Billion | 2474.99 Billion | -1.34 Million | -1.27 Million |
| Cash at beginning of period | 12.65 Million | 33.89 Million | 17.34 Million | 6.53 Million | 7.58 Million | 8.2 Million |
| Cash at end of period | 4.08 Million | 12.65 Million | 33.89 Million | 17.34 Million | 6.53 Million | 7.58 Million |
| Capital Expenditure | - | - | -97 Thousand | -63 Thousand | -22 Thousand | -564.27 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.56 Million | -21.23 Million | 16.54 Million | 10.81 Million | -1.05 Million | -623.67 Thousand |
| Free Cash Flow | -8.56 Million | -21.12 Million | -14.18 Million | -14.79 Million | -15.4 Million | -12.7 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.05 Million | -8.63 Million | -1.22 Million | -1.37 Million | -3.97 Million | -16.33 Million |
| Depreciation & Amortization | 75.00 | 250 Thousand | - | -75.00 | 122 Thousand | 1.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 39 Thousand | 159 Thousand | 44 Thousand | 53 Thousand | 23 Thousand | 953 Thousand |
| Change in working capital | -293 Thousand | 15 Thousand | 630 Thousand | -2.08 Million | 1.75 Million | -2.97 Million |
| Other non-cash items | 427.99 Thousand | 1.22 Million | -806 Thousand | 53 Thousand | -227 Thousand | -3.81 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 98 Thousand | - | - | - | -111.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -79.00 |
| Common Stock Issuance | 98 Thousand | 98 Thousand | - | - | - | -32 Thousand |
| Other Financing Activities | - | -98 Thousand | - | - | - | -32.00 |
| Accounts receivables | -390 Thousand | -920 Thousand | 850 Thousand | - | - | - |
| Accounts payables | -223 Thousand | 1.25 Million | - | - | 1.47 Million | -3.95 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 97 Thousand | 935 Thousand | -220 Thousand | -2.08 Million | -1.47 Million | 985 Thousand |
| Cash at beginning of period | 6.39 Million | 12.65 Million | 6.95 Million | 10.35 Million | 12.65 Million | 33.89 Million |
| Cash at end of period | 4.08 Million | 4.08 Million | 6.39 Million | 6.95 Million | 10.35 Million | 12.65 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.3 Million | -8.56 Million | -555 Thousand | -3.39 Million | -2.3 Million | -21.23 Million |
| Free Cash Flow | -2.3 Million | -8.56 Million | -555 Thousand | -3.39 Million | -2.3 Million | -21.12 Million |
7388
COTY
4171
LTH
3946
FINGF